Understanding how copper affects energy production in cells

Mitochondrial Copper Biology

['FUNDING_OTHER'] · TEXAS A&M AGRILIFE RESEARCH · NIH-11003282

This study is looking at how copper helps our cells grow and produce energy, especially in the tiny powerhouses called mitochondria, and it aims to find out how we can use copper to prevent serious health issues like Menkes disease, which happens when the body doesn't get enough copper.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorTEXAS A&M AGRILIFE RESEARCH (nih funded)
Locations1 site (College Station, UNITED STATES)
Trial IDNIH-11003282 on ClinicalTrials.gov

What this research studies

This research investigates the role of copper as a vital nutrient for the growth and energy production in cells, particularly focusing on its function in mitochondrial metabolism. The study aims to uncover the mechanisms of copper transport and its importance in preventing fatal disorders linked to copper deficiency, such as Menkes disease. By using various biological models, the researchers will explore how copper is delivered to mitochondria and how it can restore normal cellular respiration. The findings could lead to the development of new treatments for conditions caused by copper deficiency.

Who could benefit from this research

Good fit: Ideal candidates for this research are infants and children diagnosed with congenital copper deficiency disorders.

Not a fit: Patients with conditions unrelated to copper metabolism or those who do not have a deficiency in copper may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies for life-threatening disorders caused by copper deficiency.

How similar studies have performed: Previous research has shown promise in using similar approaches to address copper-related disorders, indicating potential for success in this area.

Where this research is happening

College Station, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: congenital hypocupraemia syndrome

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.